Opportunity Information: Apply for PAR 12 008

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition Revision(s) to the Dominantly Inherited Alzheimer Network (U19)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866 Aging Research.
  • This funding opportunity was created on Nov 8, 2011 and posted on Nov 8, 2011.
  • Applicants must submit their applications by Sep 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Apply for PAR 12 008

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The grant opportunity titled "Limited Competition Revision(s) to the Dominantly Inherited Alzheimer Network (U19)" (Funding Opportunity Number PAR-12-008) is a National Institutes of Health (NIH) discretionary funding announcement that supports revisions to an existing, funded cooperative agreement connected to the Dominantly Inherited Alzheimer Network (DIAN). DIAN is an NIH-supported research effort focused on dominantly inherited (familial) forms of Alzheimer disease, and this particular announcement is not for brand-new standalone projects. Instead, it is designed for applicants who already hold the parent DIAN U19 award and want to request additional funds or make other allowable changes through a formal "revision" application, consistent with NIH policies for revisions (often used to add scope, accelerate progress, or address newly emerging needs within the boundaries of the parent award).

The funding mechanism is a Cooperative Agreement (U19), which generally means NIH expects substantial programmatic involvement during the conduct of the project. In practical terms, a cooperative agreement often includes closer coordination with NIH program staff than a standard research project grant, and it is commonly used for large, multi-component, collaborative research programs where NIH involvement can help align activities, coordinate network functions, and ensure shared goals and milestones are met.

A key limitation in this announcement is that revision applications may not request support beyond the project end date of the parent award. That restriction matters because it effectively caps the timeline: even if the revision proposes new activities, the requested budget period must fit entirely within the remaining approved project period of the currently funded DIAN U19. So the revision is meant to enhance or modify the ongoing program rather than extend it.

This opportunity falls under the NIH funding activity category of Health and is associated with CFDA 93.866 (Aging Research). There is no cost sharing or matching requirement, which means applicants are not required to contribute non-federal funds as a condition of receiving the award, though standard NIH budget rules and allowability requirements still apply.

Eligibility is limited and somewhat specialized. The announcement indicates that eligibility is restricted (a "limited competition"), and the eligible applicant category is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)." In addition, the announcement explicitly prohibits foreign involvement in several forms: non-U.S. (foreign) institutions cannot apply; non-U.S. components of U.S. organizations are not eligible; and foreign components, as defined by the NIH Grants Policy Statement, are not allowed. Taken together, those restrictions mean the applicant organization and the supported project components must be domestic, with no foreign components included under NIH definitions.

In terms of timing, the opportunity was posted and created on November 8, 2011. The original and current closing date was September 7, 2013, and the archive date was October 8, 2013, indicating the announcement is no longer active for new submissions under that FOA. For historical reference and full details, the announcement was linked through the NIH Grants Guide (http://grants.nih.gov/grants/guide/pa-files/PAR-12-008.html). The contact information provided is primarily technical support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues (FBOWebmaster@OD.NIH.GOV), rather than a scientific or grants management point of contact.

Overall, PAR-12-008 was a time-limited NIH call for revision applications tied specifically to the DIAN U19 cooperative agreement, aimed at enabling existing DIAN awardees to propose additional or modified work within the remaining project period, under NIH cooperative agreement oversight, and with strict domestic-only participation rules.

Frequently Asked Questions (FAQs)

What is the official title and funding opportunity number for this grant?

The opportunity is titled "Limited Competition Revision(s) to the Dominantly Inherited Alzheimer Network (U19)" and the Funding Opportunity Number is PAR-12-008.

What is the purpose of PAR-12-008?

This announcement supports revision applications to an existing, funded cooperative agreement connected to the Dominantly Inherited Alzheimer Network (DIAN). It is intended for current DIAN U19 awardees who want to request additional funds or propose other allowable changes through a formal NIH "revision" application.

Is this opportunity for brand-new, standalone research projects?

No. The announcement is not for new standalone projects. It is specifically for revisions to an already funded parent DIAN U19 award.

Who is this funding opportunity meant for?

It is designed for applicants who already hold the parent DIAN U19 cooperative agreement award and are seeking to modify or enhance the funded program through a revision request, consistent with NIH revision policies.

What does "limited competition" mean in this context?

"Limited competition" indicates eligibility is restricted. The eligible applicant category is shown as "Others (see text field entitled Additional Information on Eligibility for clarification)," and the narrative description makes clear it is tied to the existing DIAN U19 parent award.

What is the funding mechanism used for this opportunity?

The mechanism is a Cooperative Agreement (U19).

What does a Cooperative Agreement (U19) imply about NIH involvement?

A cooperative agreement generally means NIH expects substantial programmatic involvement during the conduct of the project. In practice, it often involves closer coordination with NIH program staff than a standard research project grant, and it is commonly used for large, collaborative, multi-component programs such as research networks.

What is the Dominantly Inherited Alzheimer Network (DIAN)?

DIAN is an NIH-supported research effort focused on dominantly inherited (familial) forms of Alzheimer disease.

Can a revision application extend the project beyond the parent award end date?

No. A key limitation is that revision applications may not request support beyond the project end date of the parent award. Any proposed revision activities and requested budget period must fit entirely within the remaining approved project period of the current DIAN U19.

Does this FOA allow applicants to add scope or accelerate progress?

The announcement describes revisions as being consistent with NIH revision policies, which are often used to add scope, accelerate progress, or address newly emerging needs, as long as those changes remain within the boundaries of the parent award.

What is the NIH funding activity category for this opportunity?

The funding activity category listed is Health.

What CFDA number is associated with this opportunity?

The opportunity is associated with CFDA 93.866 (Aging Research).

Is cost sharing or matching required?

No. The announcement states there is no cost sharing or matching requirement.

Are foreign institutions eligible to apply?

No. Non-U.S. (foreign) institutions cannot apply under this announcement.

Are non-U.S. components of U.S. organizations eligible?

No. The announcement states that non-U.S. components of U.S. organizations are not eligible.

Are foreign components allowed in any form?

No. Foreign components, as defined by the NIH Grants Policy Statement, are not allowed.

What do the domestic-only rules mean for applicants in practical terms?

Based on the restrictions listed, the applicant organization and the supported project components must be domestic, and the application may not include foreign components under NIH definitions.

When was this opportunity posted and created?

The opportunity was posted and created on November 8, 2011.

What were the closing date and archive date?

The closing date (original and current) was September 7, 2013, and the archive date was October 8, 2013.

Is PAR-12-008 still active for new submissions?

No. The listed closing date and archive date indicate the announcement is no longer active for new submissions under this FOA.

Where was the full announcement hosted for reference?

It was linked through the NIH Grants Guide at http://grants.nih.gov/grants/guide/pa-files/PAR-12-008.html.

What contact information is provided in the opportunity description?

The contact information provided is for technical support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues: FBOWebmaster@OD.NIH.GOV.

Does the listed contact appear to be a scientific or grants management contact?

No. The contact given is described as technical support for access or linking issues, rather than a scientific or grants management point of contact.

What is the main takeaway about what PAR-12-008 funded?

It was a time-limited NIH call for revision applications tied specifically to the DIAN U19 cooperative agreement, allowing existing DIAN awardees to propose additional or modified work within the remaining project period, under NIH cooperative agreement oversight, with strict domestic-only participation rules.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Implications of the Economic Downturn for Health, Wealth, and Work at Older Ages (R01)

Previous opportunity: Methodology, Measurement, and Statistics

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 12 008

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 12 008) also looked into and applied for these:

Funding Opportunity
Implications of the Economic Downturn for Health, Wealth, and Work at Older Ages (R01) Apply for PA 12 009

Funding Number: PA 12 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers Apply for CMS 1A1 12 002

Funding Number: CMS 1A1 12 002
Agency: Centers for Medicare Medicaid Services
Category: Health
Funding Amount: $3,000,000
Support to the Zimbabwe MOH and Child Welfare s Program for PMTCT of HIV. Apply for 674 12 1003 EXPRESSION OF INTEREST

Funding Number: 674 12 1003 EXPRESSION OF INTEREST
Agency: South Africa USAID Pretoria
Category: Health
Funding Amount: $60,000,000
HIV Incidence Assays with Improved Specificity (R01) Apply for PA 12 012

Funding Number: PA 12 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Directors Early Independence Awards (DP5) Apply for RFA RM 11 007

Funding Number: RFA RM 11 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Data Coordinating Center for Autism and Other Developmental Disabilities Research and Epidemiologic Studies (U10) Apply for RFA DD 12 001

Funding Number: RFA DD 12 001
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $900,000
Area Health Education Centers Apply for HRSA 12 013

Funding Number: HRSA 12 013
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Health Care Innovation Challenge Apply for CMS 1C1 12 001

Funding Number: CMS 1C1 12 001
Agency: Centers for Medicare Medicaid Services
Category: Health
Funding Amount: $30,000,000
Research Technical Assistance To The Ministry Of Public Health Of Haiti To Support Post Earthquake Reconstruction, Cholera And HIV/AIDS Response Apply for RFA GH 12 003

Funding Number: RFA GH 12 003
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Evaluation of NIAAAs Alcohol Screening Guide for Children and Adolescents (R01) Apply for RFA AA 12 008

Funding Number: RFA AA 12 008
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Improved HIV/AIDS Services among Most at Risk Populations (MARPs) in Ukraine Apply for RFA 121 11 000003

Funding Number: RFA 121 11 000003
Agency: Ukraine USAID Kiev
Category: Health
Funding Amount: $22,000,000
Surveillance Program Announcement Behavioral Risk Factor Surveillance System, Apply for CDC RFA SO11 110102CONT12

Funding Number: CDC RFA SO11 110102CONT12
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Surveillance Program Announcement Behavioral Risk Factor Surveillance System, Apply for CDC RFA SO11 110202CONT12

Funding Number: CDC RFA SO11 110202CONT12
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Alzheimers Disease Drug Development Program (U01) Apply for PAR 12 015

Funding Number: PAR 12 015
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA MSTEM Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R25) Apply for PAR 12 016

Funding Number: PAR 12 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Rural Policy Analysis Program Apply for HRSA 12 096

Funding Number: HRSA 12 096
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Regional Hemophilia Network Apply for HRSA 12 133

Funding Number: HRSA 12 133
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $500,000
Management of HIV Related Lung Disease and Cardiovascular Co Morbidity (R34) Apply for RFA HL 12 034

Funding Number: RFA HL 12 034
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Rheumatic Diseases Research Core Centers (P30) Apply for RFA AR 12 002

Funding Number: RFA AR 12 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Technology Development to Enable Large Scale Metabolomics Analyses (R01) Apply for RFA RM 11 019

Funding Number: RFA RM 11 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 008", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.